Roles for cytosolic phospholipase A2α as revealed by gene-targeted mice

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 59-69

  Uozumi, Naonori ^a,b   Shimizu, Takao ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cytosolic phospholipase; Disease models; Gene targeted mice; Leukotrienes; Platelet activating factor; Prostaglandins

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; APC PROTEIN; ARACHIDONIC ACID; CELL ENZYME; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; LEUKOTRIENE DERIVATIVE; LIPID; LIPOXYGENASE INHIBITOR; METHACHOLINE; MUSCARINIC AGENT; NEUROTOXIN; OVALBUMIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE A2ALPHA; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; ARTICLE; ASTHMA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELL CULTURE; CHILDBIRTH; CYTOSOL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ENZYME DEFICIENCY; ENZYME REGULATION; FERTILITY; GENE TARGETING; HUMAN; INTESTINE POLYP; INTESTINE ULCER; LIPID DEGRADATION; LIPID TRANSPORT; LUNG INJURY; METABOLISM; NONHUMAN; PHENOTYPE; POLYPOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; SURVIVAL; ANIMAL; BRAIN; DISEASE MODEL; FEMALE; GENETICS; LUNG; MOUSE; PATHOLOGY; PHYSIOLOGY; PREGNANCY; REPRODUCTION; REVIEW; TRANSGENIC MOUSE;

ANAPHYLAXIS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE TARGETING; HUMANS; INTESTINAL POLYPS; LUNG; MICE; MICE, TRANSGENIC; PHOSPHOLIPASES A; PREGNANCY; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 0036669685     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00021-7     Document Type: Article

References (69)

1. 2 superfamily of signal transduction enzymes. Trends. Biochem. Sci. 22:1997;1.
2. 2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488:2000;1.
3. 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. U.S.A. 87:1990;7708.
4. 2. Biochim. Biophys. Acta. 1083:1991;80.
5. 2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266:1991;5268.
6. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043.
7. 2. J. Biol. Chem. 266:1991;14850.
8. 2. J. Lipid Mediat. Cell Signal. 12:1995;83.
9. 2. J. Biol. Chem. 272:1997;16709.
10. 2. Biochim. Biophys. Acta. 1488:2000;124.
11. 2 in allergic response and parturition. Nature. 390:1997;618.
12. 2. Nature. 390:1997;622.
13. 2. J. Biol. Chem. 269:1994;23250.
14. 2, probing the role of histidine, aspartic acid, cysteine, and arginine. J. Biol. Chem. 271:1996;19225.
15. 2 reveals a novel topology and catalytic mechanism. Cell. 97:1999;349.
16. 2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell. 81:1995;957.
17. 2 gene in inbred mouse strains. J. Biol. Chem. 270:1995;22378.
18. 2. Am. J. Physiol. Renal Physiol. 280:2001;F607.
19. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1999;1193.
20. 2 gene. J. Biol. Chem. 275:2000;34013.
21. Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M.et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 91:1997;197.
22. Lim H., Gupta R.A., Ma W.G., Paria B.C., Moller D.E., Morrow J.D.et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARΔ Genes Dev. 13:1999;1561.
23. Kennedy C.R., Zhang Y., Brandon S., Guan Y., Coffee K., Funk C.D.et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat. Med. 5:1999;217.
24. Hizaki H., Segi E., Sugimoto Y., Hirose M., Saji T., Ushikubi F.et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10501.
25. Matsumoto H., Ma W., Smalley W., Trzaskos J., Breyer R.M., Dey S.K. Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol. Reprod. 64:2001;1557.
26. Gross G.A., Imamura T., Luedke C., Vogt S.K., Olson L.M., Nelson D.M.et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11875.
27. Sugimoto Y., Yamasaki A., Segi E., Tsuboi K., Aze Y., Nishimura T.et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 277:1997;681.
28. Tsuboi K., Sugimoto Y., Iwane A., Yamamoto K., Yamamoto S., Ichikawa A. Uterine expression of prostaglandin H2 synthase in late pregnancy and during parturition in prostaglandin F receptor-deficient mice. Endocrinology. 141:2000;315.
29. 2 regulation. J. Biol. Chem. 275:2000;20146.
30. 2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273:1998;441.
31. 2-mediated regulation of phospholipase D2 in leukocyte cell lines. J. Immunol. 163:1999;5462.
32. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4803.
33. 2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells. Biochem. J. 352:2000;311.
34. 2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271:2000;812.
35. Oettgen H.C., Martin T.R., Wynshaw-Boris A., Deng C., Drazen J.M., Leder P. Active anaphylaxis in IgE-deficient mice. Nature. 370:1994;367.
36. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S.et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187:1998;1779.
37. Ishii S., Nagase T., Tashiro F., Ikuta K., Sato S., Waga I.et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16:1997;133.
38. Nagase T., Ishii S., Katayama H., Fukuchi Y., Ouchi Y., Shimizu T. Airway responsiveness in transgenic mice overexpressing platelet- activating factor receptor. Roles of thromboxanes and leukotrienes. Am. J. Respir. Crit. Care Med. 156:1997;1621.
39. Irvin C.G., Tu Y.P., Sheller J.R., Funk C.D. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol. 272:1997;L1053.
40. 2 as a mediator of allergic asthma. Science. 287:2000;2013.
41. 2. Nat. Immunol. 1:2000;42.
42. Weinacker A.B., Vaszar L.T. Acute respiratory distress syndrome: physiology and new management strategies. Annu. Rev. Med. 52:2001;221.
43. Nagase T., Ishii S., Kume K., Uozumi N., Izumi T., Ouchi Y.et al. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 104:1999;1071.
44. Bazan N.G., Squinto S.P., Braquet P., Panetta T., Marcheselli V.L. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system. Lipids. 26:1991;1236.
45. 2 and its role in brain tissue. J. Neurochem. 69:1997;889.
46. 2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci. Lett. 233:1997;97.
47. 2) activity in gerbil brain: characterization of cytosolic and membrane-associated forms and effects of ischemia and reperfusion on enzymatic activity. J. Lipid. Mediat. 6:1993;457.
48. 2 and the increased gene expression in the dentate gyrus following transient forebrain ischemia. Brain. Res. Mol. Brain. Res. 25:1994;364.
49. 2 after transient global forebrain ischemia in the rat. Stroke. 27:1996;527.
50. 2 are resistant to MPTP neurotoxicity. J. Neurochem. 71:1998;2634.
51. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803.
52. Yang V.W., Shields J.M., Hamilton S.R., Spannhake E.W., Hubbard W.C., Hylind L.M.et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res. 58:1998;1750.
53. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J. Natl. Cancer Inst. 90:1998;1529.
54. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J. Natl. Cancer Inst. 90:1998;1609.
55. Dubois R.N. Review article: cyclooxygenase - a target for colon cancer prevention. Aliment. Pharmacol. Ther. 14(Suppl 1):2000;64.
56. Prescott S.M., Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta. 1470:2000;M69.
57. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C.et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 256:1992;668.
58. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4482.
59. Min-induced tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3935.
60. Cormier R.T., Hong K.H., Halberg R.B., Hawkins T.L., Richardson P., Mulherkar R.et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 17:1997;88.
61. Cormier R.T., Bilger A., Lillich A.J., Halberg R.B., Hong K.H., Gould K.A.et al. The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene. 19:2000;3182.
62. Δ716 knockout mice. Nat. Med. 7:2001;1048.
63. Nguyen M., Camenisch T., Snouwaert J.N., Hicks E., Coffman T.M., Anderson P.A.et al. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature. 390:1997;78.
64. Segi E., Sugimoto Y., Yamasaki A., Aze Y., Oida H., Nishimura T.et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem. Biophys. Res. Commun. 246:1998;7.
65. 2-deficient mice. Gastroenterology. 120:2001;1193.
66. 2 messenger RNA mainly in neurons in the rat brain. Neuroscience. 92:1999;1061.
67. Kato K., Uruno K., Saito K., Kato H. Both arachidonic acid and 1-oleoyl-2-acetyl glycerol in low magnesium solution induce long-term potentiation in hippocampal CA1 neurons in vitro. Brain Res. 563:1991;94.
68. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S.et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 410:2001;471.
69. 2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br. J. Pharmacol. 133:2001;438.